https://www.selleckchem.com/pr....oducts/atuzabrutinib
Upper gastrointestinal (GI) bleeding is associated with increased morbidity and mortality. Tranexamic acid (TXA) is an antifibrinolytic agent which is licensed in the management of haemorrhage associated with trauma. It has been suggested that tranexamic acid may be able to play a role in upper GI bleeding. However, there is currently no recommendation to support this. The aim of this study was to synthesise available evidence of the effect of TXA on upper GI bleeding. A systematic review was conducted. PubMed, EMBASE, and Cochran
إعجاب
علق
شارك
